# Oramed Pharmaceuticals Inc.: filings

ORMP · Nasdaq · CIK 1176309 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ormp.md) · [Financials](/companies/ormp/financials.md) · [Filings](/companies/ormp/filings.md) · [Insiders](/companies/ormp/insiders.md)

## Reports and events: 333 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 241, 8-K 217, 10-Q 54, 424B3 39, 3 25, 10-K 17, SC 13G/A 17, 424B5 16, DEF 14A 15, EFFECT 14, UPLOAD 13, CORRESP 10, SC 13G 9, 424B7 8, 4/A 8, S-8 8, SCHEDULE 13G/A 8, ARS 7, CT ORDER 7, S-3 7, SC 13D/A 7, PRE 14A 6, D 5, S-1 5, SC 13D 5, 144 4, D/A 4, POS AM 4, SCHEDULE 13D/A 4, SCHEDULE 13D 3, 10-K/A 2, 8-A12B 2, NT 10-Q 2, S-1/A 2, SCHEDULE 13G 2, 10-Q/A 1, 10-QT 1, 3/A 1, 5 1, 8-K/A 1, CERTNAS 1, DEFA14A 1, FWP 1, NT 10-K 1, PRER14A 1, RW 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-17 | 19:37 ET | [8-K](/filings/0001213900-26-100929.md) | 5.07 Shareholder vote results | 0001213900-26-100929 |
| 2026-08-10 | 21:29 ET | [10-Q](/filings/0001213900-26-087361.md) | Quarterly report, period 2026-06-30 | 0001213900-26-087361 |
| 2026-08-03 | 20:05 ET | [DEF 14A](/filings/0001213900-26-084609.md) | Proxy statement, period 2026-09-15 | 0001213900-26-084609 |
| 2026-07-22 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001213900-26-080406.md) | Ownership report, active investor, amended | 0001213900-26-080406 |
| 2026-06-30 | 20:19 ET | [8-K](/filings/0001213900-26-073709.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-073709 |
| 2026-06-17 | 20:48 ET | [SCHEDULE 13D/A](/filings/0001213900-26-069783.md) | Ownership report, active investor, amended | 0001213900-26-069783 |
| 2026-05-19 | 21:08 ET | [10-Q](/filings/0001213900-26-059112.md) | Quarterly report, period 2026-03-31 | 0001213900-26-059112 |
| 2026-05-14 | 17:19 ET | [SCHEDULE 13D](/filings/0001213900-26-056837.md) | Ownership report, active investor | 0001213900-26-056837 |
| 2026-03-31 | 20:20 ET | [8-K](/filings/0001213900-26-037474.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition | 0001213900-26-037474 |
| 2026-03-26 | 21:14 ET | [10-K](/filings/0001213900-26-034835.md) | Annual report, period 2025-12-31 | 0001213900-26-034835 |
| 2026-02-20 | 21:26 ET | [8-K](/filings/0001012975-26-000195.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001012975-26-000195 |
| 2026-02-19 | 21:50 ET | [SCHEDULE 13D/A](/filings/0001213900-26-018576.md) | Ownership report, active investor, amended | 0001213900-26-018576 |
| 2026-01-29 | 16:44 ET | [SCHEDULE 13D](/filings/0001213900-26-009570.md) | Ownership report, active investor | 0001213900-26-009570 |
| 2026-01-14 | 21:31 ET | [8-K](/filings/0001213900-26-004382.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-004382 |
| 2026-01-07 | 13:56 ET | [8-K](/filings/0001213900-26-001983.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-001983 |
| 2025-12-31 | 21:30 ET | [8-K](/filings/0001213900-25-127133.md) | 5.02 Departure or appointment of officers or directors | 0001213900-25-127133 |
| 2025-12-31 | 01:51 ET | [8-K](/filings/0001012975-25-000992.md) | 8.01 Other events | 0001012975-25-000992 |
| 2025-11-17 | 14:05 ET | [8-K](/filings/0001213900-25-111310.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-111310 |
| 2025-11-17 | 13:50 ET | [8-K](/filings/0001213900-25-111298.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001213900-25-111298 |
| 2025-11-13 | 21:07 ET | [10-Q](/filings/0001213900-25-109980.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109980 |
| 2025-10-24 | 23:39 ET | [8-K](/filings/0001213900-25-101825.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-101825 |
| 2025-10-06 | 13:28 ET | [8-K](/filings/0001213900-25-096322.md) | 8.01 Other events | 0001213900-25-096322 |
| 2025-08-28 | 20:01 ET | [SCHEDULE 13D/A](/filings/0001213900-25-081720.md) | Ownership report, active investor, amended | 0001213900-25-081720 |
| 2025-08-21 | 20:06 ET | [8-K](/filings/0001213900-25-079361.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-25-079361 |
| 2025-08-14 | 20:11 ET | [10-Q](/filings/0001213900-25-076668.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076668 |
| 2025-07-23 | 12:36 ET | [8-K](/filings/0001213900-25-066819.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-066819 |
| 2025-07-16 | 21:08 ET | [DEF 14A](/filings/0001213900-25-064755.md) | Proxy statement, period 2025-08-19 | 0001213900-25-064755 |
| 2025-07-16 | 20:05 ET | [10-K/A](/filings/0001213900-25-064678.md) | Annual report, amended, period 2024-12-31 | 0001213900-25-064678 |
| 2025-05-21 | 20:05 ET | [8-K](/filings/0001213900-25-046436.md) | 8.01 Other events | 0001213900-25-046436 |
| 2025-05-15 | 20:06 ET | [10-Q](/filings/0001213900-25-044193.md) | Quarterly report, period 2025-03-31 | 0001213900-25-044193 |
| 2025-05-01 | 13:59 ET | [SCHEDULE 13D](/filings/0001213900-25-038294.md) | Ownership report, active investor | 0001213900-25-038294 |
| 2025-04-28 | 20:30 ET | [8-K](/filings/0001213900-25-036109.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-036109 |
| 2025-03-27 | 21:00 ET | [10-K](/filings/0001013762-25-003450.md) | Annual report, period 2024-12-31 | 0001013762-25-003450 |
| 2025-03-03 | 21:30 ET | [8-K](/filings/0001213900-25-019437.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-019437 |
| 2025-02-27 | 22:00 ET | [8-K](/filings/0001213900-25-018135.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-018135 |
| 2025-02-11 | 21:35 ET | [8-K](/filings/0001213900-25-012244.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-012244 |
| 2025-01-22 | 14:18 ET | [8-K](/filings/0001213900-25-005212.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-005212 |
| 2025-01-03 | 13:31 ET | [8-K](/filings/0001213900-25-000517.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-000517 |
| 2024-12-17 | 21:55 ET | [8-K](/filings/0001213900-24-109825.md) | 8.01 Other events | 0001213900-24-109825 |
| 2024-11-07 | 21:05 ET | [10-Q](/filings/0001213900-24-095397.md) | Quarterly report, period 2024-09-30 | 0001213900-24-095397 |
| 2024-10-29 | 21:01 ET | [8-K](/filings/0001213900-24-091795.md) | 8.01 Other events | 0001213900-24-091795 |
| 2024-10-08 | 18:12 ET | [8-K](/filings/0001213900-24-086214.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-086214 |
| 2024-09-26 | 20:05 ET | [8-K](/filings/0001213900-24-082237.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-082237 |
| 2024-09-23 | 12:06 ET | [8-K](/filings/0001213900-24-080812.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-080812 |
| 2024-08-14 | 20:05 ET | [10-Q](/filings/0001213900-24-068992.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068992 |
| 2024-08-02 | 20:05 ET | [8-K](/filings/0001213900-24-064732.md) | 5.07 Shareholder vote results | 0001213900-24-064732 |
| 2024-06-26 | 13:00 ET | [8-K](/filings/0001213900-24-055950.md) | 8.01 Other events | 0001213900-24-055950 |
| 2024-06-24 | 13:00 ET | [8-K](/filings/0001213900-24-055006.md) | 8.01 Other events | 0001213900-24-055006 |
| 2024-06-20 | 11:30 ET | [DEF 14A](/filings/0001213900-24-054007.md) | Proxy statement, period 2024-08-01 | 0001213900-24-054007 |
| 2024-06-10 | 21:28 ET | [8-K](/filings/0001213900-24-051355.md) | 5.02 Departure or appointment of officers or directors | 0001213900-24-051355 |

Page 1 of 7. [Older](/companies/ormp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.